What Obama's Support for Stem Cell Research Means for California
By Joe Mathews,
Scientific American
| 05. 21. 2009
BURLINGAME, Calif.—California provides more funding for stem cell research than the other 49 states combined. So what does President Obama's executive order lifting the restrictions financing and structure of the California Institute for Regenerative Medicine (CIRM), the state's cash-strapped stem cell agency?
Not much.
see moreAt recent meetings, the members of CIRM's governing board have made clear that they see changes in federal policy as good news, but not as something that should slow down their funding or change their plans. "This is what the voters of California wish their dollars to go for," said Sherry Lansing, a former studio executive who is a leading voice on the board, during a meeting here earlier this year. "That has been something they have made quite clear, and we have a mission that we have to complete no matter what happens at the federal level." During the same discussion, Phil Pizzo, dean of the Stanford University School of Medicine, warned that whatever the National Institutes of Health ultimately funds in stem cell research, "it's not going to be with this intense focus on...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...